Dutasteride Tablet 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose in patients with hepatic impairment has not been established because there are no data on the administration of this medicine to patients with hepatic impairment.

This medication is absorbed through the skin, so women who are pregnant or may become pregnant should not handle it directly. In particular, touching damaged or broken pieces of this medication should be avoided, as it poses a risk of affecting the development of the external genitalia of a male fetus. This medication should not be administered to children under 18 years of age, and care should be taken to ensure that children do not come into contact with pieces of this medication. Women should not take this medication, nor should individuals with allergies to this medication or its components, or individuals with hypersensitivity to 5-alpha reductase inhibitors, be administered this drug. Adult men planning to conceive should use this medication with caution under a doctor's guidance, due to potential effects on fertility. In addition, patients with significant urinary retention or severe urinary reduction should be carefully monitored for urinary obstruction symptoms while taking this medication. Patients with liver function abnormalities should use this medication cautiously, as it may be affected by its metabolism. Patients who are chronically taking strong CYP3A4 inhibitors should be cautious, as they may experience increased blood levels of this medication. This medication is primarily used for treating benign prostatic hyperplasia and male pattern hair loss in men, and it may cause genital-related adverse reactions such as erectile dysfunction, decreased libido, ejaculation disorders, and gynecomastia during treatment. These adverse reactions may persist even after discontinuation of the medication. Long-term use of this medication does not increase the frequency of adverse reactions, but there may be a slight increase in the risk of high-grade prostate cancer, so regular prostate cancer screening is recommended. Patients taking this medication should refrain from donating blood, and at least 6 months should pass after the last dose before blood donation is allowed. Since the prostate-specific antigen (PSA) level decreases after taking this medication, PSA levels should be reassessed 3-6 months after treatment based on the initial value before administration. This medication is unlikely to affect the ability to drive or operate machinery. There is no specific antidote in cases of overdose, and due to the long half-life of the drug, appropriate supportive care is needed. Keep out of reach of children and store in the original container to prevent misuse or degradation of quality.

• erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorder
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain its effectiveness for a longer period.

Appearance

Yellow, oblong, film-coated tablet

Package unit

30 tablets (10 tablets/PTPX3)